Apg Asset Management N.V. Neurocrine Biosciences Inc Transaction History

Apg Asset Management N.V.

$33.8 Billion
Q1 2025

A detailed history of Apg Asset Management N.V. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Apg Asset Management N.V. holds 57,942 shares of NBIX stock, worth $7.24 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

57,942

Previous 60,189 3.73%

Holding current value

$7.24 Million

Previous $8.22 Million 22.0%

% of portfolio

0.02%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$107.22 - $153.29 $240,923 - $344,442	-2,247 Reduced 3.73%	57,942 $6.41 Million
Q4 2024 Feb 13, 2025	BUY	$111.62 - $139.44 $6.72 Million - $8.39 Million	60,189 New	60,189 $8.22 Million
Q2 2024 Aug 14, 2024	SELL	$130.86 - $143.19 $15.7 Million - $17.2 Million	-119,803 Reduced 31.77%	257,315 $35.4 Million
Q1 2024 May 14, 2024	SELL	$130.4 - $143.74 $707,550 - $779,933	-5,426 Reduced 1.42%	377,118 $52 Million
Q4 2023 Feb 13, 2024	BUY	$106.07 - $132.76 $4.95 Million - $6.2 Million	46,685 Added 13.9%	382,544 $50.4 Million
Q3 2023 Nov 14, 2023	BUY	$94.02 - $117.1 $2.01 Million - $2.5 Million	21,378 Added 6.8%	335,859 $37.8 Million
Q2 2023 Aug 14, 2023	SELL	$89.53 - $104.87 $1.1 Million - $1.29 Million	-12,265 Reduced 3.75%	314,481 $29.7 Million
Q1 2023 May 12, 2023	BUY	$94.11 - $123.02 $1.46 Million - $1.9 Million	15,466 Added 4.97%	326,746 $33.1 Million
Q4 2022 Feb 14, 2023	BUY	$106.72 - $127.06 $8.21 Million - $9.78 Million	76,960 Added 32.84%	311,280 $37.2 Million
Q3 2022 Nov 14, 2022	SELL	$92.03 - $107.81 $8.2 Million - $9.6 Million	-89,056 Reduced 27.54%	234,320 $25.4 Million
Q2 2022 Aug 12, 2022	BUY	$75.79 - $100.07 $111,108 - $146,702	1,466 Added 0.46%	323,376 $30.2 Million
Q1 2022 May 12, 2022	SELL	$72.45 - $94.81 $43,470 - $56,886	-600 Reduced 0.19%	321,910 $27.1 Million
Q4 2021 Feb 11, 2022	BUY	$79.65 - $106.22 $25.1 Million - $33.4 Million	314,900 Added 4137.98%	322,510 $24.2 Million
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $129,270 - $148,545	-1,500 Reduced 16.47%	7,610 $630,000
Q2 2021 Aug 13, 2021	SELL	$89.43 - $102.27 $9.78 Million - $11.2 Million	-109,346 Reduced 92.31%	9,110 $748,000
Q1 2021 May 14, 2021	SELL	$87.57 - $119.4 $4.19 Million - $5.71 Million	-47,837 Reduced 28.77%	118,456 $9.8 Million
Q4 2020 Feb 12, 2021	SELL	$86.91 - $108.33 $1.8 Million - $2.24 Million	-20,695 Reduced 11.07%	166,293 $13 Million
Q3 2020 Nov 12, 2020	BUY	$96.16 - $135.15 $4.37 Million - $6.14 Million	45,409 Added 32.07%	186,988 $15.3 Million
Q2 2020 Aug 14, 2020	BUY	$85.09 - $130.36 $3.4 Million - $5.21 Million	40,000 Added 39.38%	141,579 $15.4 Million
Q1 2020 May 15, 2020	BUY	$75.11 - $113.76 $7.63 Million - $11.6 Million	101,579 New	101,579 $8.79 Million
Q1 2020 May 14, 2020	SELL	$75.11 - $113.76 $4.13 Million - $6.26 Million	-55,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$86.8 - $118.57 $4.77 Million - $6.52 Million	55,000 New	55,000 $5.27 Million

Others Institutions Holding NBIX

# of Institutions

649

Shares Held

97.1M

Call Options Held

749K

Put Options Held

553K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.

Account

Apg Asset Management N.V. Neurocrine Biosciences Inc Transaction History